copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
CSL Behring - Wikipedia In 2007, ZLB Behring became CSL Behring In 2009, ZLB Plasma changed its name to CSL Plasma to align with its parent company and opened plasma testing laboratories in Knoxville, Tennessee
Global Biotechnology Company - CSL CSL Behring is a global biotherapeutics leader driven by our promise to save lives Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas
Our Story - CSL Behring With the approval of Sandoglobulin® Liquid NF (IVIg) and Vivaglobin® (subcutaneous Ig), ZLB Behring is the only company to offer patients in Canada with primary immune deficiencies two immunglobulin formulations
CSL Behring Products Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry CSL Behring: Rare Serious Diseases Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers
Our Company - CSL Behring In the century since, CSL Behring has grown into a global biotechnology leader, driven by that same promise to save and improve lives We offer the broadest range of quality plasma-derived and recombinant therapies in our industry
CSL Behring United Kingdom CSL Behring is committed to improving the quality of life for people with rare and serious diseases worldwide This commitment is reflected in our support of programmes and activities for patients with rare plasma-protein related diseases, including bleeding disorders and primary and secondary immune deficiencies
Worldwide Locations - CSL Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry CSL Behring: Rare Serious Diseases Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers
CSL Behring - History - LiquiSearch As part of a global alignment, the CSL Behring brand was established in 2007 Previously known as ZLB Behring, the company has a long history dating back to 1904 CSL Behring traces its heritage back to Emil von Behring, the inventor of serum therapy or serology
Global Biotechnology Company | CSL CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency